Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Liu

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
World Journal of Gastroenterology|January 31, 2002
Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinomaD H Liu, X Y Zhang, D M Fan, et al.
Bone Marrow Transplantation|January 21, 2014
Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinibX-D Mo, Q Jiang, L-P Xu, et al.
Bone Marrow Transplantation|November 8, 2011
Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysisY Wang, D-H Liu, L-P Xu, et al.
Bone Marrow Transplantation|January 20, 2015
A retrospective comparison of BU-fludarabine and BU-CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCTY-Q Sun, L-P Xu, X-H Zhang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 17, 2011
The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletionY-Q Sun, L-P Xu, D-H Liu, et al.
Bone Marrow Transplantation|December 3, 2013
Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trialY Wang, H-X Fu, D-H Liu, et al.
Bone Marrow Transplantation|July 30, 2013
Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemiaD-H Liu, L-P Xu, K-Y Liu, et al.
Bone Marrow Transplantation|August 3, 2006
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignanciesX-J Huang, D-H Liu, K-Y Liu, et al.
Bone Marrow Transplantation|June 3, 2014
Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignancesX-D Mo, X-Y Zhao, D-H Liu, et al.
Bone Marrow Transplantation|November 12, 2014
Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndromeX-D Mo, L-P Xu, X-H Zhang, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
World Journal of Gastroenterology|January 31, 2002
Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinomaD H Liu, X Y Zhang, D M Fan, et al.
Bone Marrow Transplantation|January 21, 2014
Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinibX-D Mo, Q Jiang, L-P Xu, et al.
Bone Marrow Transplantation|November 8, 2011
Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysisY Wang, D-H Liu, L-P Xu, et al.
Bone Marrow Transplantation|January 20, 2015
A retrospective comparison of BU-fludarabine and BU-CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCTY-Q Sun, L-P Xu, X-H Zhang, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 17, 2011
The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletionY-Q Sun, L-P Xu, D-H Liu, et al.
Bone Marrow Transplantation|December 3, 2013
Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trialY Wang, H-X Fu, D-H Liu, et al.
Bone Marrow Transplantation|July 30, 2013
Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemiaD-H Liu, L-P Xu, K-Y Liu, et al.
Bone Marrow Transplantation|August 3, 2006
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignanciesX-J Huang, D-H Liu, K-Y Liu, et al.
Bone Marrow Transplantation|June 3, 2014
Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignancesX-D Mo, X-Y Zhao, D-H Liu, et al.
Bone Marrow Transplantation|November 12, 2014
Chronic GVHD induced GVL effect after unmanipulated haploidentical hematopoietic SCT for AML and myelodysplastic syndromeX-D Mo, L-P Xu, X-H Zhang, et al.
Pageof 13